IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 39 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $19,000 | -9.5% | 45,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $21,000 | -4.5% | 45,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $22,000 | -33.3% | 45,000 | 0.0% | 0.00% | -50.0% |
| Q4 2014 | $33,000 | -17.5% | 45,000 | 0.0% | 0.00% | -33.3% |
| Q3 2014 | $40,000 | -20.0% | 45,000 | 0.0% | 0.00% | -25.0% |
| Q2 2014 | $50,000 | -9.1% | 45,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $55,000 | +31.0% | 45,000 | 0.0% | 0.00% | +33.3% |
| Q4 2013 | $42,000 | -59.2% | 45,000 | +12.5% | 0.00% | -50.0% |
| Q3 2013 | $103,000 | +32.1% | 40,000 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $78,000 | – | 40,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Callan Capital, LLC | 70,000 | $65,000 | 0.02% |
| Wellington Shields Capital Management, LLC | 51,000 | $47,000 | 0.01% |
| Ifrah Financial Services, Inc. | 18,500 | $17,000 | 0.01% |
| CHELSEA COUNSEL CO | 28,000 | $26,000 | 0.01% |
| DRW Securities, LLC | 120,000 | $111,000 | 0.01% |
| TUDOR INVESTMENT CORP ET AL | 66,303 | $61,000 | 0.00% |
| OPPENHEIMER & CO INC | 107,000 | $99,000 | 0.00% |
| First Allied Advisory Services, Inc. | 45,000 | $42,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $65,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 160,103 | $148,000 | 0.00% |